Therapeutic Expertise

CARDIOVASCULAR

Enhancing results via quick thinking, agility, and data-driven understanding

The primary cause of death worldwide is still cardiovascular disease, despite enormous advancements in improving cardiovascular outcomes. Cardiovascular disease and treatment quality are still pressing public health concerns that require quick, flexible, and data-driven insights to improve results.

We are a global leader in cardiovascular drug development, or cardiovascular CRO. This includes small to medium-sized biotech businesses that rely on our dedicated Cardiovascular team for our depth of therapeutic knowledge, inventive, adaptable solutions, and help with your most challenging problems.

Our experience includes dyslipidemia, diabetes, obesity, thrombosis, heart failure, atrial fibrillation, ischemic heart disease, and hypertension. We have conducted large-scale international cardiovascular outcome trials (CVOT) and have expertise in novel medicines like stem cells, HFpEF, HFrEF, and SGLT-2 inhibitors.

ONCOLOGY

Fervent about working together to find a cure

The study and understanding of cancer are in their "golden age" right now. Thanks to developments in genetics, immunotherapy, and precision medicine, we are learning more about tumour cells and can now directly influence them, resulting in longer survival times.

Our therapeutic knowledge in cancer is extensive and profound, going well beyond a conventional CRO. Preclinical and translational science, clinical development, regulatory, and commercialization/marketing capabilities are all included in our oncology service offerings.

We pay great attention to your needs, then use our worldwide organization's knowledge, insights, and skills to provide well-considered, integrated solutions that will help you reach your objectives.

RESPIRATORY

Facilitating patients' breathing

Throughout the world, respiratory disorders are among the main causes of mortality and disability. These include lung cancer, pneumonia, asthma, and COPD, as well as rare and severe illnesses such interstitial lung disease, cystic fibrosis, and hypereosinophilic syndrome.

Time is critical for all respiratory illnesses. Abiozen is the go-to CRO partner for developing novel treatments from clinical research to commercialization. Our respiratory team is highly skilled, with clinical, regulatory, and commercialization capabilities.

We are committed to furthering novel treatments for: Asthma, COPD, Allergic rhinitis, RSV infection, and Rare Diseases including interstitial lung disease and Cystic fibrosis.

DERMATOLOGY

Expanding upon the potential of innovation

Massive advancements in everything from skin cancer diagnosis to the development of cell and gene therapies for hereditary and uncommon skin conditions are reshaping the field.

We offer comprehensive clinical development and therapeutic knowledge driven by insights from across the clinical to commercial spectrum. From Phase I research to commercialization, our specialists offer flexible, integrated solutions.

Clinical trials have been undertaken for skincare and medical aesthetics, as well as psoriasis, atopic dermatitis, acne, alopecia, and skin cancer.

GASTROENTEROLOGY

New treatments are sorely needed worldwide. Our dedicated gastroenterology/hepatology staff is knowledgeable on the wide range of digestive diseases. We collaborate closely with investigators and KOLs throughout the world.

Our experience includes: Celiac disease, colitis, diverticulitis, GERD, gastric surgery, inflammatory bowel disease (IBD) including Crohn’s Disease and ulcerative colitis, IBS, and non-alcoholic fatty liver disease (NAFLD/NASH).

NEUROLOGY

Committed to advancing the science and art of neurology drug discovery

Neurology research requires a unique combination of scientific depth and elegant problem-solving to counter placebo effects and measure subjective endpoints.

At Abiozen, we combine rigorous research with operational excellence and deep strategic thinking to carry out your neuroscience clinical trial effectively and economically.

PAEDIATRICS

One of the most vulnerable groups in clinical research. We give you direct access to knowledge in pediatric clinical research, including the specific clinical and legal know-how needed when collaborating with patient populations who are at risk and their families.

NEPHROLOGY

here is a greater need than ever for the 850 million people who suffer from renal disease. We cleverly connect and integrate real-world data, past site performance, and analytics to power your trial from the outset.

OPHTHALMOLOGY

Regarding ailments such as retinopathies, glaucoma, and dry eye. Our operational knowledge is based on state-of-the-art technology and next-generation clinical data to expedite your schedules and accomplish benchmarks.

GENERAL MEDICINE

Our thought leaders offer creative development techniques as well as moral trial design and management. They collaborate closely with operational teams and market access experts to guarantee trials are carried out to the highest standards.

Offering operational agility and strategic insight at every stage of development.